Issuer disclosure record

$OREX

Company name unavailable

Transactions involving this ticker in readable 2013–2026 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.

Purchases

Sales

Filers

Reports

Transaction history

Who disclosed trading $OREX?

Open in trade feed →

saleRep. Alan S. LowenthalCA-47

$OREXOrexigen Therapeutics, Inc. (OREX)

Rep. Alan S. Lowenthal's filing reports that a spouse account sold · $11.99

View transaction source status →

Traded Jan 5, 2018Notified Jan 11, 2018Filed Jan 23, 201818 days to file

Owner: SpouseView original filing →